Savara’s $100 Million Common Stock Offering

Laura Testa
Tagged:

Holland & Knight advised Savara on the offering.Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $100 million underwritten…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

…

This content is for Standard 1 Year members only.
Login Join Now